Catabasis Pharma (CATB) – Corporate News
-
Catabasis Pharma (CATB) Phase 3 PolarisDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy Did Not Meet Primary Endpoint
-
Catabasis Pharma (CATB) Announces Noah Clauser as CFO
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CATB Stock Lookup